Initially, the first priority was to have access to vaccines from big pharma, which was done. The Canadian federal government did very well there by signing seven contracts.
The second priority was to build up from day one, not to wait to build up capacity in Canada. This meant that, from the beginning, there was a need to increase the volume of vaccine and manufacturing, knowing very well that PPEs had been an issue and would continue to be an issue.